Food & Health
Novartis Halts CAR-T Trials Amid Fatal Risks
Explore the valuation impact after Novartis paused CAR-T trials due to patient deaths. Sector-wide safety concerns rise.
Food & Health
Explore the valuation impact after Novartis paused CAR-T trials due to patient deaths. Sector-wide safety concerns rise.